Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo. Rastogi N, Baker S, Man S, Uger RA, et al. Br J Haematol 2021;193:155-159.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rastogi N, Baker S, Man S, Uger RA, et al. Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo. Br J Haematol 2021;193:155-159.
PMID: 32996123